FDA
-
-
-
-
-
-
-
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
-
-
-
-
-
-
-
PureTech Health plc – Half-Year Report
-
-
-
-
-
-
-
PureTech Provides End of Year Report on Key Progress
-
-
-
-
-
-
-
PureTech Health Plc's (PRTC) Vor Biopharma (VOR) Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
-
-
-
-
-
-
-
Vor To Present on VOR33 Manufacturing Scale-Up and Off-Target Editing at ASGCT
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

